We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
(+6.2%)
Cap. Flow
-$64.1M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10
Avg Time Held
3.1
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$14.8M |
| 2 |
Henry Schein
HSIC
|
+$14.3M |
| 3 |
Honeywell
HON
|
+$14.2M |
| 4 |
Pediatrix Medical
MD
|
+$13.5M |
| 5 |
Charles River Laboratories
CRL
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.1M |
| 2 |
CVS Health
CVS
|
+$18M |
| 3 |
Accendra Health
ACH
|
+$14.8M |
| 4 |
Ubiquiti
UI
|
+$13.1M |
| 5 |
Eagle Bancorp
EGBN
|
+$11.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.91% |
| 2 | Healthcare | 16.24% |
| 3 | Technology | 15.4% |
| 4 | Industrials | 13.98% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Procter & Gamble
PG
$365B
| $38.2M | 0.56% |
415,262
-48,481
| -10% | -$4.36M |
2013 Q2
18 quarters
|
|
52
Chemed
CHE
$6.74B
| $37.8M | 0.55% |
155,692
-20,689
| -12% | -$4.7M |
2015 Q3
9 quarters
|
|
53
Choice Hotels
CHH
$4.81B
| $37.4M | 0.55% |
482,062
-9,045
| -2% | -$661K |
2014 Q3
13 quarters
|
|
54
Commerce Bancshares
CBSH
$7.97B
| $37.3M | 0.55% |
986,419
-10,873
| -1% | -$405K |
2013 Q2
18 quarters
|
|
55
DELISTED
Eaton Vance Corp.
EV
| $37.1M | 0.54% |
657,152
-61,665
| -9% | -$3.26M |
2013 Q2
18 quarters
|
|
56
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $35.7M | 0.52% |
539,933
-6,288
| -1% | -$416K |
2016 Q2
6 quarters
|
|
57
Hershey
HSY
$33.9B
| $35.7M | 0.52% |
314,730
-3,845
| -1% | -$423K |
2015 Q3
9 quarters
|
|
58
Merck
MRK
$358B
| $35.6M | 0.52% |
663,573
-25,335
| -4% | -$1.4M |
2013 Q2
18 quarters
|
|
59
DELISTED
Coresite Realty Corporation
COR
| $35.4M | 0.52% |
310,369
-4,442
| -1% | -$506K |
2013 Q2
18 quarters
|
|
60
Church & Dwight Co
CHD
$24.5B
| $34.9M | 0.51% |
696,298
+123,600
| +22% | +$5.8M |
2013 Q2
18 quarters
|
|
61
Alphabet (Google) Class A
GOOGL
$4.27T
| $34.5M | 0.51% |
654,760
-7,540
| -1% | -$389K |
2015 Q3
9 quarters
|
|
62
Bank of Hawaii
BOH
$2.65B
| $33.6M | 0.49% |
392,322
-10,856
| -3% | -$905K |
2013 Q2
18 quarters
|
|
63
DELISTED
SunTrust Banks, Inc.
STI
| $33.6M | 0.49% |
520,395
+25,095
| +5% | +$1.53M |
2013 Q2
18 quarters
|
|
64
Applied Industrial Technologies
AIT
$12.3B
| $33.3M | 0.49% |
489,051
-4,591
| -0.9% | -$292K |
2015 Q1
11 quarters
|
|
|
DST
65
DELISTED
DST Systems Inc.
DST
| $32.6M | 0.48% |
525,744
-4,180
| -0.8% | -$248K |
2015 Q4
8 quarters
|
|
66
W.W. Grainger
GWW
$62.7B
| $32M | 0.47% |
135,474
-6,005
| -4% | -$1.24M |
2013 Q2
18 quarters
|
|
|
TECD
67
DELISTED
Tech Data Corp
TECD
| $31.1M | 0.46% |
317,681
+36,304
| +13% | +$3.4M |
2014 Q2
14 quarters
|
|
68
DELISTED
Discover Financial Services
DFS
| $31M | 0.45% |
402,870
+1,133
| +0.3% | +$77.9K |
2015 Q4
8 quarters
|
|
69
Unifirst Corp
UNF
$4.79B
| $30.4M | 0.45% |
184,250
-2,920
| -2% | -$465K |
2013 Q4
16 quarters
|
|
70
Valmont Industries
VMI
$8.71B
| $30.2M | 0.44% |
182,236
+2,843
| +2% | +$462K |
2015 Q1
11 quarters
|
|
71
Teradata
TDC
$2.91B
| $30M | 0.44% |
781,063
+101,097
| +15% | +$3.61M |
2013 Q2
18 quarters
|
|
72
Franklin Electric
FELE
$4.45B
| $29M | 0.43% |
632,104
-14,213
| -2% | -$642K |
2013 Q2
18 quarters
|
|
73
Estee Lauder
EL
$38.8B
| $28.8M | 0.42% |
226,587
-550
| -0.2% | -$66.1K |
2017 Q2
2 quarters
|
|
74
Dollar General
DG
$29.5B
| $28.5M | 0.42% |
306,376
+3,145
| +1% | +$270K |
2015 Q2
10 quarters
|
|
75
DELISTED
Praxair Inc
PX
| $28.4M | 0.42% |
183,485
-7,811
| -4% | -$1.16M |
2013 Q2
18 quarters
|
|
Similar funds
Boston Trust Walden's Q4 2017 Portfolio in Review
As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
- Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
- Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
- Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
- Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
- Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
- Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.
Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.